Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Ucb Biopharma Sprl
Ucb Biopharma Sprl A Corporation

Ucb Biopharma Sprl patents


Recent patent applications related to Ucb Biopharma Sprl. Ucb Biopharma Sprl is listed as an Agent/Assignee. Note: Ucb Biopharma Sprl may have other listings under different names/spellings. We're not affiliated with Ucb Biopharma Sprl, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "U" | Ucb Biopharma Sprl-related inventors


 new patent  Auto-injector

Provided is a cassette unit suitable for use with an auto-injector having a drive unit. The cassette unit comprises a cassette unit housing defining a cassette unit housing cavity arranged for receipt of a syringe; a needle projection aperture; a needle cover defining a needle sheath for sheathing of a... Ucb Biopharma Sprl

Method for protein purification

The present invention provides a method for recovering a human VH3 domain-containing antibody in monomeric form. In particular the present invention provides a new method that allows recovery of monomeric human VH3 domain-containing antibodies from a mixture containing monomeric and multimeric forms of the antibody.... Ucb Biopharma Sprl

A specific trifluoroethyl quinoline analogue for use in the treatment of sjögren's syndrome

N-{(R)-1-[8-Chloro-2-(1-oxypyridin-3-yl)-quinolin-3-yl]-2,2,2-trifluoroethyl}-pyrido[3,2-d]pyrimidin-4-ylamine is effective in the treatment and/or prevention of Sjögren's syndrome.... Ucb Biopharma Sprl

Auto-injector and drive unit therefor

Provided is a drive unit for an auto-injector having a drive unit housing arranged for docking receipt of a syringe or of a cassette unit comprising a syringe movable from a rest position, in which a needle tip of the syringe is within the drive unit housing to a use... Ucb Biopharma Sprl

Systems and methods for administering medication

The syringe systems disclosed herein provide in part devices for allowing patients with compromised joint strength to more easily administer medicine. Certain exemplary syringe embodiments include a handle forming a handgrip, a syringe barrel that magnifies the dosage marks located on an inner barrel, and a tip cap slidably engageable... Ucb Biopharma Sprl

Method of generating, storing and mining data related to key opinion leaders in scientific fields and computer system configured for presenting an explorable graphical user interface

A method of storing and ingesting data related to key opinion leaders is provided. The method includes extracting published works data, individual data, organization data and subject matter data for a plurality of published scientific works to identify entities for each of the published scientific works and storing the published... Ucb Biopharma Sprl

Auto-injector and drive unit therefor

Provided is a drive unit for an auto-injector having a drive unit housing arranged for docking receipt of a syringe or of a cassette unit comprising a syringe movable from a rest position, in which a needle tip of the syringe is within the drive unit housing to a use... Ucb Biopharma Sprl

Polymeric fc proteins and methods of screening to alter their functional characteristics

The invention relates to polymeric Fc proteins which bind to human Fc-receptors and methods of screening said polymeric Fc proteins to alter their functional characteristics. The invention also relates to therapeutic compositions comprising the polymeric Fc proteins, and their use in the treatment of immune disorders.... Ucb Biopharma Sprl

Epitopes of il-17a and il-17f and antibodies specific thereto

The present invention relates neutralising epitopes of IL-17A and IL-17F and antibodies which bind those epitopes. The present invention also relates to the therapeutic uses of the antibody molecules and methods for producing them.... Ucb Biopharma Sprl

Pharmaceutical formulation

The current invention relates to a new pharmaceutical formulation, in particular to a pharmaceutical formulation comprising a protein, more particularly an antibody as an active ingredient.... Ucb Biopharma Sprl

Combination treatment

The present invention relates and the combination of lacosamide and brivaracetam for the preparation of a fixed dose combination that is useful in the treatment of epilepsy, epileptogenesis, seizure disorders and convulsions.... Ucb Biopharma Sprl

9h-pyrrolo-dipyridine derivatives

The invention relates to 9H-pyrrolo-dipyridine derivatives of formula I, processes for preparing them, pharmaceutical compositions containing them and their use as radiopharmaceuticals in particular as imaging agents for the detection of Tau aggregates.... Ucb Biopharma Sprl

Treatment of autoimmune disorders with cd154 antibodies

The present invention relates to a method of treating an autoimmune or inflammatory disease or a neurodegenerative disease with an antibody to CD154.... Ucb Biopharma Sprl

Protein manufacture

The present invention provides a novel method for protein manufacture wherein the protein is expressed in a host cell, and in a more specific manner relates to a method for manufacturing a protein that results in reduced levels of product-related impurities.... Ucb Biopharma Sprl

Method of protein manufacture

The present invention provides a novel method for manufacturing a protein, particularly where said protein is to be coupled with another molecule. The invention further provides a method for industrial scale protein manufacturing to obtain proteins, e.g., for therapeutic purposes.... Ucb Biopharma Sprl

Isoindoline derivatives

The present invention relates to isoindoline derivatives according to formula (I), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.... Ucb Biopharma Sprl

Tetrahydroisoquinoline derivatives

The present invention relates to tetrahydroisoquinoline derivatives according to formula (I), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.... Ucb Biopharma Sprl

Fused pentacyclic imidazole derivatives

A series of fused pentacyclic imidazole derivatives, being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders. In... Ucb Biopharma Sprl

Neutralising antibody molecules having specificity for human il-17

The invention relates to an antibody molecule having specificity for antigenic determinants of IL-17, therapeutic uses of the antibody molecule and methods for producing said antibody molecule.... Ucb Biopharma Sprl

Housing part for an anto-injector

Provided is a housing part for an auto-injector comprising a shell form body defining inner and outer shell surfaces and comprising a relatively hard or generally incompressible material; an over-coating formed of a relatively softer or more compressible material, the over-coating covering at least part of the outer shell surface... Ucb Biopharma Sprl

Method and system for quantifying the likelihood that a gene is casually linked to a disease

A computer program product, disposed on a non-transitory computer readable media, for analyzing a biological relevance of a candidate gene to a human phenotype is provided. The product includes computer executable process steps operable to control a computer to receive an input phenotype comprised of a plurality of input human... Ucb Biopharma Sprl

Molecules with specificity for cd79 and cd22

The present disclosure relates to multispecific molecule comprising a binding domain specific to the antigen CD22 and a binding domain specific to the antigen CD79a and/or CD79b, compositions comprising the same and use of both in treatment, for example the treatment of autoimmune disease.... Ucb Biopharma Sprl

Molecules with specificity for cd45 and cd79

The present disclosure relates to a multispecific molecule comprising a binding domain specific to the antigen CD45 and a binding domain specific to the antigen CD79a and/or CD79b, compositions comprising same and use of each in treatment, for example treatment of autoimmune disease.... Ucb Biopharma Sprl

Multispecific antibody constructs

The present disclosure relates to a multi-specific antibody molecule comprising or consisting of: a) a polypeptide chain of formula (I): VH—CH1—X—V1; and b) a polypeptide chain of formula (II): VL-CL-Y—V2 and pharmaceutical formulations comprising, for example for use in treatment. The disclosure also provides polynucleotide sequences encoding said multispecific antibody... Ucb Biopharma Sprl

Imidazopyridine derivatives as modulators of tnf activity

A series of substituted 1H imidazo[4,5-c]pyridine derivatives of formula (I), being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and... Ucb Biopharma Sprl

Method for determining antibody specificity

The present invention relates to a method for determining antibody specificity, whether a multivalent antibody is monospecific, particularly whether a bivalent antibody is monospecific or bispecific. Furthermore the invention provides a method for quantifying the amount of bispecific bivalent antibody present in a sample.... Ucb Biopharma Sprl

Biological products

There is disclosed antibody molecules containing at least one CDR derived from a mouse monoclonal antibody having specificity for human CD22. There is also disclosed a CDR grafted antibody wherein at least one of the CDRs is a modified CDR. Further disclosed are DNA sequences encoding the chains of the... Ucb Biopharma Sprl

Method and system for generating and displaying structured topics of a healthcare treatment taxonomy in different formats

A computerized method for generating and displaying structured topics of a taxonomy in different formats is provided. The computerized method includes generating a categorized topic viewer graphical user interface allowing a user to select a textual model defining a corpus of documents to explore by delimiting a healthcare treatment product;... Ucb Biopharma Sprl

Method and system for generating and displaying topics in raw uncategorized data and for categorizing such data

A computerized method for searching and organizing a healthcare textual data set is provided. The method includes receiving, by a server including a processor and a memory, an input of a user of a selected healthcare treatment product delimiting a subject data set; displaying, in response to the input subject... Ucb Biopharma Sprl

Method and system for generating and visually displaying inter-relativity between topics of a healthcare treatment taxonomy

A computerized method for displaying categorized healthcare textual data after a taxonomy has been applied to a data set is provided. The method includes generating a visual network generator graphical user interface configured to display a visual network comprised of a plurality of nodes and links, each of the nodes... Ucb Biopharma Sprl

Fused imidazole and pyrazole derivatives as modulators of tnf activity

A series of substituted benzimidazole, imidazo[1,2-α]pyridine and pyrazolo[1,5-α]pyridine derivatives, and analogues thereof, being potent modulators of human TNFα activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular... Ucb Biopharma Sprl

Tetrahydroimidazopyridine derivatives as modulators of tnf activity

A series of substituted 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine derivatives, being potent treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.... Ucb Biopharma Sprl

Triazolopyridazine derivatives as modulators of tnf activity

A series of substituted [1,2,4]triazolo[4,3-b]pyridazine derivatives of formula (I), being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological... Ucb Biopharma Sprl

Fused bicyclic heteroaromatic derivatives as kinase inhibitors

A series of fused bicyclic heteroaromatic derivatives of formula (IA) or (IB), as defined herein, being selective inhibitors of phosphatidylinositol-4-kinase IIIβ (PI4KIIIβ) activity, are beneficial in the treatment and/or prevention of various human ailments, including inflammatory, autoimmune and oncological disorders; viral diseases and malaria; and organ and cell transplant rejection.... Ucb Biopharma Sprl

Pyrazolo-pyridine derivatives as kinase inhibitors

A series of pyrazolo[3,4-b]pyridine derivatives that are substituted at the 4-position by a diaza monocyclic, bridged bicyclic or spirocyclic moiety, being selective inhibitors of phosphatidylinositol-4-kinase IIIβ (PI4KIIIβ) activity, are beneficial in the treatment and/or prevention of various human ailments, including inflammatory, autoimmune and oncological disorders; viral diseases and malaria; and... Ucb Biopharma Sprl

05/04/17 / #20170121337

Fused bicyclic heteroaromatic derivatives as kinase inhibitors

A series of fused bicyclic heteroaromatic derivatives of formula (I), as defined herein, being selective inhibitors of phosphatidylinositol-4-kinase IIIβ (PI4KIIIβ) activity, are beneficial in the treatment and/or prevention of various human ailments, including inflammatory, autoimmune and oncological disorders; viral diseases and malaria; and organ and cell transplant rejection.... Ucb Biopharma Sprl

04/20/17 / #20170105988

Pharmaceutical compositions comprising levocetirizine

The present invention relates to a pharmaceutical composition comprising levocetirizine. The invention relates specifically to a dry syrup formulation.... Ucb Biopharma Sprl

03/30/17 / #20170088603

Multimeric fc proteins

The invention relates to multimeric fusion proteins which bind to human Fc receptors. The invention also relates to therapeutic compositions comprising the proteins, and their use in the treatment of immune disorders.... Ucb Biopharma Sprl

03/23/17 / #20170081321

Pyrazolopyridine derivatives as modulators of tnf activity

A series of substituted pyrazolo[1,5-a]pyridine derivatives, being potent modulators of human TNFα activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.... Ucb Biopharma Sprl

03/23/17 / #20170081404

New bispecific format suitable for use in high-through-put screening

The present disclosure relates to a novel bispecific protein complex and a method of using the complexes to screen for synergistic or novel biological function. The bispecific format is particularly suitable for high-throughput screening because all of its components can be expressed from cells as individual units and the units... Ucb Biopharma Sprl

03/23/17 / #20170081406

Multimeric fc proteins

The invention relates to multimeric fusion proteins which bind to human Fc receptors. The invention also relates to therapeutic compositions comprising the proteins, and their use in the treatment of immune disorders.... Ucb Biopharma Sprl

02/02/17 / #20170029505

Multimeric fc proteins

The invention relates to multimeric proteins which bind to human Fc receptors. The invention also relates to therapeutic compositions comprising the proteins, and their use in the treatment of immune and other disorders.... Ucb Biopharma Sprl

01/12/17 / #20170007763

Auto-injector

Provided is a cassette unit suitable for use with an auto-injector having a drive unit. The cassette unit comprises a cassette unit housing defining a cassette unit housing cavity, which is in receipt of a syringe, a rearward entrance to said cavity and a forward needle projection aperture. The cassette... Ucb Biopharma Sprl

01/05/17 / #20170000955

Auto-injector

Provided is a cassette unit suitable for use with an auto-injector having a drive unit. The cassette unit comprises a cassette unit housing defining a cassette unit housing cavity arranged for receipt of a syringe; a needle projection aperture; a needle cover defining a needle sheath for sheathing of a... Ucb Biopharma Sprl

01/05/17 / #20170002378

Synthetic promoters

CHO cell-specific synthetic promoter constructs for expressing recombinant proteins, a library of promoter constructs thereof, and a method for producing the promoter constructs. The promoter constructs enable precise control of recombinant gene transcription over three orders of magnitude, with the top expressing promoters capable of double the transcriptional activity of... Ucb Biopharma Sprl








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Ucb Biopharma Sprl in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Ucb Biopharma Sprl with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###